{
  "company": {
    "name": "Neusignal Therapeutics, Inc.",
    "website": "https://neusignal-tx.com/",
    "record": "https://startuphistory.org/c/neusignal-tx.com"
  },
  "status": null,
  "history_since": "2026-11-13T11:12:42.308Z",
  "baseline": {
    "snapshot_id": "ca7cbf85f8a30adddf7c4194b4a615262a77380bfe2cc09b5f15041886692d8a",
    "observed_at": "2026-11-13T11:12:42.308Z",
    "headline": "Neusignal Therapeutics | Defeat dementia for a better tomorrow",
    "description": "Neusignal Therapeuticsは、アルツハイマー型認知症（AD）治療候補化合物NTX-083の開発に取り組んでいます。",
    "evidence": "https://neusignal-tx.com/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-13T11:12:42.308Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-13T11:12:42.308Z",
      "variants": [
        {
          "headline": "Neusignal Therapeutics | Defeat dementia for a better tomorrow",
          "subhead": "Neusignal Therapeuticsは、アルツハイマー型認知症（AD）治療候補化合物NTX-083の開発に取り組んでいます。",
          "observed_at": "2026-11-13T11:12:42.308Z",
          "evidence": "https://neusignal-tx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Neusignal Therapeutics | Defeat dementia for a better tomorrow",
      "subhead": "Neusignal Therapeuticsは、アルツハイマー型認知症（AD）治療候補化合物NTX-083の開発に取り組んでいます。",
      "from": "2026-11-13T11:12:42.308Z",
      "to": "2026-11-13T11:12:42.308Z",
      "captures": 1,
      "evidence": "https://neusignal-tx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-13T11:12:42.308Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Newleos Therapeutics",
      "record": "https://startuphistory.org/c/newleos.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Cybin",
      "record": "https://startuphistory.org/c/cybin.com",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Inovia Bio",
      "record": "https://startuphistory.org/c/inovia.bio",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Sironax",
      "record": "https://startuphistory.org/c/sironax.com",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Modulight Biotherapeutics",
      "record": "https://startuphistory.org/c/modulight.bio",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Navion Neurosciences",
      "record": "https://startuphistory.org/c/navionneuro.com",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Neusignal Therapeutics, Inc.” company record, https://startuphistory.org/c/neusignal-tx.com"
}